Bandhan Healthcare Fund - Regular Plan - IDCW Payout
Bandhan Asset Management Company Limited
₹10.69 (+0.79%)
NAV as of 9 Oct 2026
Minimum Investment: ₹1,000
Return
0.00% Returns for 1Y
Expense ratio & Others
- Net expense ratio
- 2.39%
- Exit load
- 0%
- Lock-in
- No
- Minimum investment
- ₹1,000
- Category
- Sector - Healthcare
Expense ratio is inclusive of GST. Returns may be taxed based on the fund type and your holding period — please read the scheme-related documents and consult a tax advisor. Figures are historical and do not guarantee future results.
Fund Returns Estimator
One-time investment
₹1,000
6 months
₹1,149
Invested ₹1,000
▲+14.93%1 year
₹1,000
Invested ₹1,000
▲+0.00%
Based on the fund’s historic trailing returns — a planning illustration, not a guarantee of future results.
Invest One-TimePlan it your way
The figures above are fixed to this fund’s past returns over set periods. Use a calculator to set your own amount, tenure and expected rate of return.
Risk level
Riskometer scale
- Low
- Low to Moderate
- Moderate
- Moderate to High
- High
- Very HighThis fund
Riskometer level assigned by the fund house as per SEBI norms. It can change as the scheme’s portfolio changes.
Fund benchmark
| Primary Index Name | BSE Healthcare PR INR |
|---|---|
| Secondary Index Name | BSE Healthcare PR INR |
| Index Name | BSE Healthcare TR INR |
| Weighting | 100% |
Returns
| 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|
| Fund returns (%) | +0.00% | — | — | — |
| Cumulative returns (%) | +0.00% | — | — | — |
Fund Manager
| Manager | Gaurav Satra |
|---|---|
| Role | Manager |
| Manager Tenure | 0.84 yrs |
About Fund
| Date of Incorporation | 28 Nov 2025 |
|---|---|
| Fund House | Bandhan Asset Management Company Limited |
| Custodian | Deutsche Bank AG |
| Registrar / Transfer Agent | Bandhan Asset Management Company Limited |
| Address | 1 Great Winchester Street |
Top Holdings
| Company | Weightage (%) |
|---|---|
| Sun Pharmaceuticals Industries Ltd | 10.48% |
| Cipla Ltd | 6.38% |
| Max Healthcare Institute Ltd Ordinary Shares | 5.81% |
| Apollo Hospitals Enterprise Ltd | 5.64% |
| Torrent Pharmaceuticals Ltd | 4.50% |
| Divi's Laboratories Ltd | 4.28% |
| Aurobindo Pharma Ltd | 4.14% |
| Lupin Ltd | 3.96% |
| Shilpa Medicare Ltd | 3.72% |
| GlaxoSmithKline Pharmaceuticals Ltd | 3.68% |
| Global Health Ltd | 3.61% |
| Glenmark Pharmaceuticals Ltd | 3.50% |
| Dr Reddy's Laboratories Ltd | 3.48% |
| Dr. Lal PathLabs Ltd | 3.46% |
Investment Strategy
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors. Disclaimer: There is no assurance or guarantee that the scheme’s objectives will be realised.
Mutual fund investments are subject to market risks. Read all scheme-related documents carefully. The data shown is for information only and does not constitute investment advice.